Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4423)
All Articles published online
|
Nov 28, 2007 (publication date) through Feb 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ponz-Sarvisé M, Rodríguez J, Viudez A, Chopitea A, Calvo A, García-Foncillas J, Gil-Bazo I. Epidermal growth factor receptor inhibitors in colorectal cancer treatment: What’s new? World J Gastroenterol 2007; 13(44): 5877-5887 [PMID: 17990353 DOI: 10.3748/wjg.v13.i44.5877] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i44/5877.htm |
| Number | Citing Articles |
| 1 |
F. Perrone, A. Lampis, M. Orsenigo, M. Di Bartolomeo, A. Gevorgyan, M. Losa, M. Frattini, C. Riva, S. Andreola, E. Bajetta, L. Bertario, E. Leo, M.A. Pierotti, S. Pilotti. PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients. Annals of Oncology 2009; 20(1): 84 doi: 10.1093/annonc/mdn541
|
| 2 |
Valda C. Hilliard, Mark R. Frey, Peter J. Dempsey, Richard M. Peek, D. Brent Polk. TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival. American Journal of Physiology-Gastrointestinal and Liver Physiology 2011; 301(2): G338 doi: 10.1152/ajpgi.00057.2011
|
| 3 |
Amir Saber, Beitollah Alipour, Zeinab Faghfoori, Ahmad Yari Khosroushahi. Cellular and molecular effects of yeast probiotics on cancer. Critical Reviews in Microbiology 2017; 43(1): 96 doi: 10.1080/1040841X.2016.1179622
|
| 4 |
Victoria A. Joshi, Raju Kucherlapati. Genetics and Genomics in the Practice of Medicine. Gastroenterology 2008; 134(5): 1284 doi: 10.1053/j.gastro.2008.03.046
|
| 5 |
Arun AZAD, Niall C TEBBUTT. Predicting the response to targeted therapy in metastatic colorectal cancer. Asia-Pacific Journal of Clinical Oncology 2008; 4(4): 208 doi: 10.1111/j.1743-7563.2008.00215.x
|
| 6 |
Liu Hong, Yu Han, Lubi Brain. Epidermal growth factor receptor: an important target in esophageal cancer. Expert Opinion on Therapeutic Targets 2013; 17(10): 1179 doi: 10.1517/14728222.2013.820709
|
| 7 |
Masanori Nakashima, Seiji Adachi, Ichiro Yasuda, Takahiro Yamauchi, Junji Kawaguchi, Toshimasa Hanamatsu, Takashi Yoshioka, Yukio Okano, Yoshinobu Hirose, Osamu Kozawa, Hisataka Moriwaki. Inhibition of Rho-associated coiled-coil containing protein kinase enhances the activation of epidermal growth factor receptor in pancreatic cancer cells. Molecular Cancer 2011; 10(1) doi: 10.1186/1476-4598-10-79
|
| 8 |
Pierpaolo Correale, Monica Marra, Cinzia Remondo, Cristina Migali, Gabriella Misso, Felice Paolo Arcuri, Maria Teresa Del Vecchio, Antonietta Carducci, Lucia Loiacono, Pierfrancesco Tassone, Alberto Abbruzzese, Pierosandro Tagliaferri, Michele Caraglia. Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC). European Journal of Cancer 2010; 46(9): 1703 doi: 10.1016/j.ejca.2010.03.005
|
| 9 |
Allison M. Cushman-Vokoun. Molecular Genetics and Personalized Medicine. 2012; : 51 doi: 10.1007/978-1-61779-530-5_4
|
| 10 |
DE Heron, JE Shogan, JW Mucenski. Innovations in chemotherapy and radiation therapy: Implications and opportunities for the Asia-Pacific Rim. Biomedical Imaging and Intervention Journal 2008; 4(3) doi: 10.2349/biij.4.3.e40
|
| 11 |
Petra Martin, Sinead Noonan, Michael P Mullen, Caitriona Scaife, Miriam Tosetto, Blathnaid Nolan, Kieran Wynne, John Hyland, Kieran Sheahan, Giuliano Elia, Diarmuid O’Donoghue, David Fennelly, Jacintha O’Sullivan. Predicting response to vascular endothelial growth factor inhibitor and chemotherapy in metastatic colorectal cancer. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-887
|
| 12 |
Qiong Wang, Yiqun Chen, Jaeyoung Park, Xiao Liu, Yifeng Hu, Tiexin Wang, Kevin McFarland, Michael J. Betenbaugh. Design and Production of Bispecific Antibodies. Antibodies 2019; 8(3): 43 doi: 10.3390/antib8030043
|
| 13 |
Georgios Giamas, Yik L. Man, Heidrun Hirner, Joachim Bischof, Klaus Kramer, Kalimullah Khan, Sharmeen S. Lavina Ahmed, Justin Stebbing, Uwe Knippschild. Kinases as targets in the treatment of solid tumors. Cellular Signalling 2010; 22(7): 984 doi: 10.1016/j.cellsig.2010.01.011
|
| 14 |
Sameera Karnam, Radhika Kottu, Amit Kumar Chowhan, Prasad Chandramouleswara Bodepati. Expression of p53 & epidermal growth factor receptor in glioblastoma. Indian Journal of Medical Research 2017; 146(6): 738 doi: 10.4103/ijmr.IJMR_1179_15
|
| 15 |
Shereen Sayed Taha Ahmed, John Refaat Fahim, Khayrya A. Youssif, Mohamed N. Amin, Hossam M.H. Abdel-Aziz, Ibrahim A. Khadra, Mostafa E. Rateb, Usama Ramadan Abdelmohsen, Ashraf Nageeb Elsayed Hamed. Comparative study of the chemical composition and anti-proliferative activities of the aerial parts and roots of Apium graveolens L. (celery) and their biogenic nanoparticles. South African Journal of Botany 2022; 151: 34 doi: 10.1016/j.sajb.2021.11.002
|
| 16 |
Vaishali Gupta, Taha Bharmal, Vineeta Dixit, Naveen Kumar Vishvakarma, Atul Kumar Tiwari, Dhananjay Shukla, Shirish Shukla. Colon Cancer Diagnosis and Therapy. 2021; : 219 doi: 10.1007/978-3-030-63369-1_11
|
| 17 |
Linda A. Feagins, Rhonda F. Souza, Stuart J. Spechler. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nature Reviews Gastroenterology & Hepatology 2009; 6(5): 297 doi: 10.1038/nrgastro.2009.44
|
| 18 |
P. Correale, C. Botta, M.G. Cusi, M.T. Del Vecchio, M.M. De Santi, G. Gori Savellini, E. Bestoso, S. Apollinari, S. Mannucci, M. Marra, A. Abbruzzese, A. Aquino, M. Turriziani, L. Bonmassar, M. Caraglia, P. Tagliaferri. Cetuximab ± chemotherapy enhances dendritic cell‐mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen‐specific cytotoxic T‐cell response in vitro. International Journal of Cancer 2012; 130(7): 1577 doi: 10.1002/ijc.26181
|
| 19 |
Li‐li Zhao, Kan‐lun Xu, Shan‐wei Wang, Bai‐lai Hu, Li‐rong Chen. Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas. Histopathology 2012; 61(4): 726 doi: 10.1111/j.1365-2559.2012.04354.x
|
| 20 |
John M. Carethers. Review: Systemic treatment of advanced colorectal cancer: Tailoring therapy to the tumor. Therapeutic Advances in Gastroenterology 2008; 1(1): 33 doi: 10.1177/1756283X08093607
|
| 21 |
Claus-Henning Köhne, Heinz-Josef Lenz. Chemotherapy with Targeted Agents for the Treatment of Metastatic Colorectal Cancer. The Oncologist 2009; 14(5): 478 doi: 10.1634/theoncologist.2008-0202
|
| 22 |
Daekee Lee, Ming Yu, Eunjung Lee, Hyunok Kim, Yanan Yang, Kyoungmi Kim, Christina Pannicia, Jonathan M. Kurie, David W. Threadgill. Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium. Journal of Clinical Investigation 2009; 119(9): 2702 doi: 10.1172/JCI36435
|
| 23 |
Elke Jäger. Sport und körperliche Aktivität in der Onkologie. 2012; : 241 doi: 10.1007/978-3-642-25066-8_23
|
| 24 |
Xinhua Chen, Johannes Fruehauf, Jeffrey D. Goldsmith, Hua Xu, Kianoosh K. Katchar, Hon–Wai Koon, Dezheng Zhao, Efi G. Kokkotou, Charalabos Pothoulakis, Ciarán P. Kelly. Saccharomyces boulardii Inhibits EGF Receptor Signaling and Intestinal Tumor Growth in Apc Mice. Gastroenterology 2009; 137(3): 914 doi: 10.1053/j.gastro.2009.05.050
|
| 25 |
Dina K. Patel. Clinical Use of Anti‐Epidermal Growth Factor Receptor Monoclonal Antibodies in Metastatic Colorectal Cancer. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2008; 28(11P2) doi: 10.1592/phco.28.11-supp.31S
|
| 26 |
Bo-Young Oh, Ryung-Ah Lee, Soon-Sup Chung, Kwang Ho Kim. Epidermal Growth Factor Receptor Mutations in Colorectal Cancer Patients. Journal of the Korean Society of Coloproctology 2011; 27(3): 127 doi: 10.3393/jksc.2011.27.3.127
|
| 27 |
|
| 28 |
Mark R. Wick, Paul E. Swanson, Alberto M. Marchevsky. Evidence Based Pathology and Laboratory Medicine. 2011; : 261 doi: 10.1007/978-1-4419-1030-1_16
|
| 29 |
Sami El Khatib, Mohamed Salla. The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics. Leukemia Research Reports 2022; 18: 100335 doi: 10.1016/j.lrr.2022.100335
|
| 30 |
Bo-Young Oh, Ryung-Ah Lee, Soon-Sup Chung, Kwang Ho Kim. Clinical Relevance of EGFR Mutations in Colorectal Cancer Patients. The Ewha Medical Journal 2013; 36(1): 51 doi: 10.12771/emj.2013.36.1.51
|
| 31 |
R Elledge. Current concepts in research related to oncogenes implicated in salivary gland tumourigenesis: a review of the literature. Oral Diseases 2009; 15(4): 249 doi: 10.1111/j.1601-0825.2009.01529.x
|
| 32 |
Pankaj Kumar, Bharti Mangla, Shamama Javed, Waquar Ahsan, Pankaj Musyuni, Aarif Ahsan, Geeta Aggarwal. Gefitinib: An Updated Review of its Role in the Cancer Management, its
Nanotechnological Interventions, Recent Patents and Clinical Trials. Recent Patents on Anti-Cancer Drug Discovery 2023; 18(4): 448 doi: 10.2174/1574892818666221026164940
|